ICD-10 Code for Prostate Cancer (C61) Explained

Prostate cancer ICD-10 coding is unusually simple compared with most oncology categories: there's one code, C61, and it's valid for submission exactly as it stands. This guide walks through what C61 covers, how metastatic prostate cancer ICD-10 coding works when the disease has spread, and how C61 differs from two codes it's often confused with — bladder cancer and urothelial carcinoma. This is a coding and billing reference, not medical or diagnostic guidance.

What is the ICD-10 code for prostate cancer?

The ICD-10 code for prostate cancer is C61, described in the official code set as "malignant neoplasm of prostate." C61 lives in Chapter 2 of ICD-10-CM, "Neoplasms" (C00-D49), alongside malignant, in-situ, benign, and uncertain-behaviour neoplasms for every organ system, organised by site rather than by cancer type.

What makes C61 worth calling out is what it doesn't need. Most neoplasm categories, and much of ICD-10-CM generally, require a fourth, fifth, or sixth character to reach a billable level of specificity — laterality, anatomical subsite, or encounter type. C61 skips all of that. As a category, it has no subdivisions: there's no C61.1 or C61.2 to choose between. The three-character code is the complete, billable entry. That's a genuinely distinctive feature of this code, and it's one of the more common points of confusion for coders used to chasing extra digits.

Why doesn't C61 need further subdivision?

The prostate is a single, non-paired gland, so there's no laterality to record. And ICD-10-CM diagnosis codes generally don't encode histology or stage — those details live in pathology reports, staging documentation, or separate data fields, not in the diagnosis code itself. With no site variation and no laterality, there's nothing left for extra characters to specify, so the category stops at three digits.

Metastatic prostate cancer ICD-10 coding

Metastatic prostate cancer ICD-10 coding follows a two-part structure that applies across ICD-10-CM's neoplasm chapter: a code for the primary site, plus a separate code — or codes — for each secondary site the cancer has spread to. For prostate cancer, that means C61 identifies the primary malignancy, and one or more codes from the C77-C79 range identify the secondary, or metastatic, sites.

The C77-C79 range covers secondary malignant neoplasms broadly: lymph nodes, respiratory and digestive organs, and other or unspecified sites, among others. Rather than listing specific sub-codes here, the general principle is what matters for coding accuracy: identify the primary site first, then add the appropriate secondary-site code or codes to reflect exactly where documentation confirms the disease has spread. Coders should always verify the specific secondary-site code against the current-year official ICD-10-CM code set and documentation, rather than assuming a code from memory or a prior year.

Sequencing matters for claims. Under the ICD-10-CM Official Guidelines for Coding and Reporting, the primary malignancy is typically sequenced first, with secondary-site codes following. Getting this order wrong, or omitting a documented secondary site, can affect claim accuracy even when the underlying codes themselves are correct. As with any coding decision, this should be checked against the current official guidelines rather than a fixed rule of thumb, since guidance is reviewed and can be updated.

How does prostate cancer's code compare with related codes?

Prostate cancer, bladder cancer, and urothelial carcinoma sit near each other conceptually — all urologic, all potentially discussed in the same clinical workup — but they are separate primary sites in ICD-10-CM, not variants of a single code. Keeping them apart matters for accurate coding.

Is bladder cancer the same as prostate cancer for coding?

No. Bladder cancer is malignant neoplasm of bladder, coded to the C67 category, which is entirely separate from C61. Unlike C61, the C67 category does subdivide by bladder subsite. If a patient has both a prostate malignancy and a separate bladder malignancy, both would typically be coded — C61 for the prostate and the relevant C67 code for the bladder — because they represent two distinct primary sites, not one condition with two names.

Is urothelial carcinoma its own code?

Not exactly. Urothelial carcinoma — sometimes still referred to by its older name, transitional cell carcinoma — is a histology, meaning a description of the cell type involved, not a body site. It most commonly arises in the bladder, in which case it's coded to the C67 bladder category, but it can also originate in the renal pelvis or ureter, in which case the code follows that site instead. There is no single, dedicated urothelial carcinoma code in ICD-10-CM; the anatomical site determines the code, and the histology is typically documented separately rather than driving code selection on its own.

A coding scenario: sequencing primary and secondary site codes

Consider a straightforward administrative example. A claim arrives documenting a primary prostate malignancy with confirmed spread to regional lymph nodes. A coder working the chart assigns C61 first, reflecting the primary site, and then adds the appropriate secondary-site code from the C77 range to capture the nodal involvement, based on what the documentation actually supports — never a code chosen by assumption.

Before submission, the coder checks two things: that C61 is sequenced ahead of the secondary-site code, consistent with the official guidelines, and that the secondary-site code matches what's documented rather than a broader or narrower site than the record supports. This kind of sequencing check is routine in oncology coding, and it's exactly where a quick, reliable reference to the current code set earns its keep — a mis-sequenced or mismatched secondary-site code is a common, avoidable source of claim rework.

Using a live ICD-10-CM reference

Because coding guidance and the underlying code set are reviewed on a regular cycle, the safest habit is to check the current official version rather than rely on a code memorised from a previous year. Patientary keeps the full ICD-10-CM code set current and searchable, alongside live NPPES provider data, so coders and developers can confirm a code like C61 — or look up the right C77-C79 or C67- entry — without leaving their workflow. For background on how the coding system is structured more broadly, see how ICD-10 codes work and what makes a code billable.

If you're new to medical coding generally, what is medical coding and ICD-10 vs CPT vs HCPCS are useful starting points before diving into site-specific codes like C61. And if you're weighing tools for day-to-day lookups, free vs paid ICD-10 lookup tools covers what to expect from each.